Management of Heartburn in a 75-Year-Old Male
Start this patient on empirical proton pump inhibitor (PPI) therapy at standard once-daily dosing if he has no alarm symptoms, but proceed directly to upper endoscopy if he presents with dysphagia, bleeding, anemia, weight loss, or recurrent vomiting. 1
Initial Assessment: Rule Out Alarm Features
First, determine if alarm symptoms are present:
- Dysphagia (difficulty swallowing)
- Bleeding (hematemesis or melena)
- Anemia
- Weight loss
- Recurrent vomiting
If ANY alarm symptom is present → Immediate upper endoscopy 1. These features suggest potential malignancy, stricture, or severe esophagitis requiring urgent evaluation. In elderly patients, weight loss and dysphagia have the best performance for identifying esophageal or gastric malignancies 2.
Management Without Alarm Symptoms
Step 1: Empirical PPI Therapy
Begin standard once-daily PPI therapy (e.g., omeprazole 20 mg, lansoprazole 30 mg) 2. PPIs are strongly recommended as first-line therapy—they are more effective than H2-receptor antagonists, which are more effective than placebo 2.
Important caveat for elderly patients: Consider early endoscopy even without alarm symptoms in this 75-year-old male, particularly if he has:
- Chronic GERD symptoms (>5 years duration)
- Additional risk factors: nocturnal reflux, hiatal hernia, elevated BMI, tobacco use, intra-abdominal fat distribution 1
The elderly often present with less severe heartburn but have more complicated disease including esophagitis, strictures, and Barrett's esophagus due to prolonged acid exposure over decades 3. Some experts recommend early endoscopy as first-line in all elderly GERD patients regardless of symptom severity 3.
Step 2: If Symptoms Persist After 4-8 Weeks
Escalate to twice-daily PPI therapy (e.g., omeprazole 20 mg twice daily) for an additional 4-8 weeks 1.
Step 3: If Symptoms Persist Despite Twice-Daily PPI
Proceed to upper endoscopy with biopsy 1. This evaluation serves multiple purposes:
- Rule out Barrett's esophagus
- Identify esophagitis or strictures
- Exclude alternative diagnoses (malignancy, eosinophilic esophagitis, peptic ulcer disease)
- Assess for eosinophilic esophagitis (obtain at least 5 esophageal biopsies even if mucosa appears normal) 2
Critical point: In elderly patients with dysphagia specifically, maintain a low threshold for obtaining multiple biopsies to evaluate for eosinophilic esophagitis, which can present atypically in older adults 2, 4.
Screening Endoscopy Considerations
Consider screening endoscopy in this 75-year-old male if he has chronic GERD symptoms (>5 years) plus multiple risk factors 1:
- Nocturnal reflux symptoms
- Hiatal hernia
- Elevated BMI
- Tobacco use
- Intra-abdominal fat distribution
However, weigh this against life-limiting comorbidities 1. The goal is detecting Barrett's esophagus and esophageal adenocarcinoma, which have higher prevalence in men over 50 with chronic reflux.
Important limitation: There is insufficient evidence that routine screening endoscopy reduces mortality from esophageal cancer 2. The AGA consensus strongly rejected that screening improves mortality, grading the evidence as insufficient 2.
Adjunctive Lifestyle Modifications
Recommend weight loss if overweight or obese (Grade B recommendation) 2.
Elevate head of bed if he experiences nighttime heartburn or regurgitation 2.
Tailor other modifications (avoiding late meals, specific trigger foods, alcohol, coffee) based on his individual symptom patterns rather than broadly enforcing all restrictions 2.
Common Pitfalls in Elderly Patients
- Atypical presentations: Elderly patients often have less frequent or severe heartburn despite more severe esophageal damage 3
- Polypharmacy: Review medications that may worsen reflux (calcium channel blockers, nitrates, anticholinergics, benzodiazepines)
- Delayed diagnosis: Lower threshold for endoscopy given higher complication rates in this age group 5, 3
- Missing eosinophilic esophagitis: Can present with dysphagia and minimal heartburn in elderly patients 4
What NOT to Do
Do not use metoclopramide as monotherapy or adjunctive therapy (Grade D recommendation—harms outweigh benefits) 2.
Do not perform routine surveillance endoscopy after initial negative screening unless Barrett's esophagus is found 1.
Do not add nocturnal H2-receptor antagonist to twice-daily PPI—no evidence of improved efficacy 2.